The Association between COVID-19 Vaccine Types and Side Effects Following Vaccination: Cross-Sectional Study
Abstract
Many experts agree and believe that the COVID-19 vaccine is the best way to control the COVID-19 pandemic in a sustainable manner. Each type of vaccine has different side effects and effectiveness. Meanwhile, information regarding the relationship between the type of COVID-19 vaccines and side effects in real populations, especially in Indonesia, is still limited. The aim of this study was to investigate the association between COVID-19 post-vaccination side effects and COVID-19 vaccine type. From April to June 2022, a cross-sectional quantitative study will be conducted in Bekasi City, West Java, Indonesia. The population consists of all 1,885,014 residents of Bekasi City who have received the first dose of COVID-19 vaccination. The samples obtained were 428 respondents from online surveys employing a purposive sampling technique. Among 428 participants, there were 50.50% received Inactivated Virus (Sinovac/Sinopharm), 23.80% Viral Vector (AstraZeneca), and 25.70% mRNA (Moderna/Pfizer-BioNTech). The adjusted analysis showed a significant correlation between the type of viral vector vaccine (OR: 26.60; 95% CI: 11.04-64.30) and the type of mRNA vaccine (OR: 1.80; 95% CI: 1.17-3.04) with side effects of COVID-19 vaccination. There was a correlation between the type of vaccines with side effects after controlled variables of sex and history of infection.
Full text article
References
Putri RN. Indonesia dalam Menghadapi Pandemi Covid-19. Jurnal Ilmiah Universitas Batanghari Jambi. 2020;20(2):705-709. http://dx.doi.org/10.33087/jiubj.v20i2.1010
Eastin C, Eastin T. Epidemiological Characteristics of 2143 Pediatric Patients with 2019 Coronavirus Disease in China. Journal of Emergency Medicine. 2020;58(4):712–713. https://doi.org/10.1016/j.jemermed.2020.04.006
WHO. Coronavirus (COVID-19) Dashboard with Vaccination Data. Geneva: World Health Organization; 2021. https://covid19.who.int/
Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. New England Journal Med. 2020;383(25):2439–2450. https://www.nejm.org/doi/10.1056/NEJMoa2027906
Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and Efficacy of the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2: an Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. https://www.sciencedirect.com/science/article/pii/S0140673620326611?via%3Dihub
Kemenkes RI. Vaksinasi COVID-19 Berdasarkan Provinsi dan Kabupaten/ Kota. Jakarta: Kementerian Kesehatan RI; 2021. https://vaksin.kemkes.go.id/#/detail_data
Machingaidze S, Wiysonge CS. Understanding COVID-19 Vaccine Hesitancy. Nature Medicine. 2021;27(8):1338–1339. http://dx.doi.org/10.1038/s41591-021-01459-7
Nossier SA. Vaccine Hesitancy: the Greatest Threat to COVID-19 Vaccination Programs. Journal of Egyptian Public Health Association. 2021;96:18. https://doi.org/10.1186/s42506-021-00081-2
Supangat, Sakinah EN, Nugraha MY, Qodar TS, Mulyono BW, Tohari AI. COVID-19 Vaccines Programs: Adverse Events Following Immunization (AEFI) among Medical Clerkship Student in Jember, Indonesia. BMC Pharmacology and Toxicology. 2021;22(1):1–7. https://doi.org/10.1186/s40360-021-00528-4
Djanas D, Yusirwan, Martini RD, Rahmadian, Putra H, Zanir A, et al. Survey Data of COVID-19 Vaccine Side Effects among Hospital Staff in A National Referral Hospital in Indonesia. Data in Brief. 2021;36(107098):1-7. https://doi.org/10.1016/j.dib.2021.107098
Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications [Internet]. 2013 [cited 2022 Jul 7]. https://books.google.co.id/books?hl=id&lr=&id=XU9ZmLe5k1IC&oi=fnd&pg=PT14&dq=lemeshow&ots=ocaXEgPwQn&sig=I5RnaUIsh2NBBiEjGWWhhT0orIk&redir_esc=y#v=onepage&q=lemeshow&f=false
Chapin J, Gee J, Myers T. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. JAMA. 2021;325(21):2201–2202. doi:10.1001/jama.2021.5374
Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, et al. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. Vaccines. 2021;9(6):1–23. https://www.mdpi.com/2076-393X/9/6/556
WHO. Side Effects of COVID-19 Vaccines. Geneva: World Health Organization; 2021. https://www.who.int/news-room/feature-stories/detail/side-effects-of-covid-19-vaccines
Riad A, Hocková B, Kantorová L, Slávik R, Spurná L, Stebel A, et al. Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia. Pharmaceuticals. 2021;14(9):1–24. https://www.mdpi.com/1424-8247/14/9/873
Tsai R, Hervey J, Hoffman K, Wood J, Johnson J, Deighton D, et al. COVID-19 Vaccine Hesitancy and Acceptance among Individuals with Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey. JMIR Public Health and Surveillance. 2022;8(1):1–16. https://publichealth.jmir.org/2022/1/e29872
Rosiello DF, Anwar S, Yufika A, Adam RY, Ismaeil MI, Ismail AY, et al. Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Ten Countries in Asia, Africa, and South America. Narra J. 2021;(May):1–16.
https://narraj.org/main/article/view/55
Elnaem MH, Mohd Taufek NH, Ab Rahman NS, Mohd Nazar NI, Zin CS, Nuffer W, et al. Covid-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter? Vaccines. 2021;9(10):1–15.
https://www.mdpi.com/2076-393X/9/10/1156
Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, et al. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines. 2021;9(6):1–8. https://www.mdpi.com/2076-393X/9/6/674
Salerno L, Craxì L, Amodio E, Lo Coco G. Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy. Vaccines. 2021;9(8):1–15. https://www.mdpi.com/2076-393X/9/8/927
Tissot N, Brunel AS, Bozon F, Rosolen B, Chirouze C, Bouiller K. Patients with History of Covid-19 Had More Side Effects After the First Dose of Covid-19 Vaccine. Vaccine. 2021;39(36):5087–5090. https://doi.org/10.1016/j.vaccine.2021.07.047
Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. Journal of Clinical Medicine. 2021;10(7):1–18. https://www.mdpi.com/2077-0383/10/7/1428
Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine Side-Effects and SARS-CoV-2 Infection After Vaccination in Users of the COVID Symptom Study App in the UK: a Prospective Observational Study. The Lancet Infectious Diseases. 2021;21(7):939–949. http://dx.doi.org/10.1016/S1473-3099(21)00224-3
Authors
Copyright (c) 2023 by author
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Copyright encompasses rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, such as electronic, electrostatic and mechanical copies, photocopies, recordings, magnetic media, etc.
All articles published Open Access are free for everyone to read and download. Under the CC-BY-NC-SA license, authors retain ownership of the copyright for their article, but authors grant others permission to use the content of publications in Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin in whole or in part provided that the original work is properly cited. Users (redistributors) of Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin are required to cite the original source, including the author's names, Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin as the initial source of publication, year of publication, and volume number.
Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin is licensed under Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.